Allelic, Genotypic, and Haplotypic Analysis of Cytokine IL17A, IL17F, and Toll-like Receptor TLR4 Gene Polymorphisms in Metabolic-Dysfunction-Associated Steatotic Liver Disease: Insights from an Exploratory Study

(1) Background: Interleukin 17 (IL17) and toll-like receptor 4 (TLR4) elevate the risk of metabolic and liver diseases. (2) Methods: This study’s objective was to explore the association of IL17 and TLR4 gene polymorphisms with MASLD susceptibility and test their effect on serum IL17 and TLR4 levels...

Full description

Saved in:
Bibliographic Details
Main Authors: Sorina-Cezara Coste, Olga Hilda Orășan, Angela Cozma, Vasile Negrean, Teodora Gabriela Alexescu, Mirela Georgiana Perne, George Ciulei, Adriana Corina Hangan, Roxana Liana Lucaciu, Mihaela Iancu, Lucia-Maria Procopciuc
Format: Article
Language:English
Published: MDPI AG 2024-10-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/14/10/1327
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:(1) Background: Interleukin 17 (IL17) and toll-like receptor 4 (TLR4) elevate the risk of metabolic and liver diseases. (2) Methods: This study’s objective was to explore the association of IL17 and TLR4 gene polymorphisms with MASLD susceptibility and test their effect on serum IL17 and TLR4 levels. A total of 43 patients with MASLD (MASH/MAFL) and 38 healthy individuals were genotyped for IL17F-<i>A7488G</i>, IL17A-<i>G197A</i>, TLR4-<i>Asp299Gly</i>, and TLR4-<i>Thr399Ile</i> polymorphisms using PCR-RFLP. ELISA methods determined IL17F, IL17A, and TLR4 serum levels. (3) Conclusions: Patients carrying the variant genotypes (<i>A/G + G/G</i>) of IL17-<i>A7448G</i> (OR = 5.25), (<i>G/A + A/A</i>) of <i>IL17-G197A</i> (OR = 10.57), (<i>Asp/Gly + Gly/Gly</i>) of TLR4-<i>Asp299Gly</i> (OR = 3.52), or (<i>Thr/Ile + Ile/Ile</i>) of TLR4-<i>Thr399Ile</i> (OR = 9.87) had significantly increased odds of MASH. Genotype (<i>G/A + A/A</i>) of IL17-<i>G197A</i> was significantly associated with the odds of MAFL (<i>p</i> = 0.0166). Allele <i>A</i> of the <i>IL17-G197A</i> polymorphism was significantly related to increased odds of MAFL (OR = 4.13, <i>p</i> = 0.0133). In contrast, allele <i>A</i> of IL17-<i>G197A</i> (OR = 5.41, <i>p</i> = 0.008), allele <i>Gly</i> of TLR4-<i>Asp299Gly</i> (OR = 3.19, <i>p</i> = 0.046), and allele <i>Ile</i> of TLR4-<i>Thr399Ile</i> (OR = 6.94, <i>p</i> = 0.008) polymorphisms were significantly related to an increased risk of MASH. Allele <i>A</i> of IL17A-<i>G197A</i>, allele <i>Gly</i> of TLR4-<i>Asp299Gly</i>, and allele <i>Ile</i> of TLR4-<i>Thr399Ile</i> gene polymorphisms were significantly associated with the increased odds of MASLD. In patients with MASLD, we found significant influence from the IL17A-<i>G197A</i> gene polymorphism on IL17F levels (<i>p</i> = 0.0343).
ISSN:2075-1729